Shares of Tilray Inc (NASDAQ:TLRY - Get Free Report) dropped 2.8% on Friday . The company traded as low as $0.47 and last traded at $0.47. Approximately 7,153,974 shares traded hands during mid-day trading, a decline of 75% from the average daily volume of 28,626,818 shares. The stock had previously closed at $0.49.
Analyst Ratings Changes
A number of analysts recently weighed in on TLRY shares. Canaccord Genuity Group increased their price target on shares of Tilray from $2.00 to $3.00 and gave the company a "buy" rating in a research report on Monday, January 13th. Piper Sandler reduced their price target on shares of Tilray from $2.00 to $1.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 9th. Finally, Roth Capital reissued a "neutral" rating on shares of Tilray in a report on Monday, April 14th.
View Our Latest Report on TLRY
Tilray Stock Performance
The company has a market capitalization of $458.06 million, a P/E ratio of -1.52 and a beta of 1.95. The stock's fifty day moving average price is $0.59 and its 200-day moving average price is $1.05. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.58 and a current ratio of 2.54.
Tilray (NASDAQ:TLRY - Get Free Report) last released its quarterly earnings data on Tuesday, April 8th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.06). Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The company had revenue of $185.78 million during the quarter, compared to analyst estimates of $213.38 million. As a group, research analysts anticipate that Tilray Inc will post -0.2 EPS for the current fiscal year.
Institutional Investors Weigh In On Tilray
Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Lido Advisors LLC bought a new position in Tilray during the 4th quarter worth $28,000. Verdence Capital Advisors LLC bought a new position in shares of Tilray during the fourth quarter worth about $29,000. Dudley Capital Management LLC acquired a new position in shares of Tilray in the fourth quarter worth approximately $29,000. Cerity Partners LLC bought a new stake in Tilray in the first quarter valued at approximately $31,000. Finally, Ameritas Advisory Services LLC acquired a new stake in Tilray during the 4th quarter valued at approximately $32,000. 9.35% of the stock is owned by institutional investors.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
See Also
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
